Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Lin, Yi Ruu ^a   Chen, Hwei Hsien ^a   Lin, Yu Chin ^b   Ko, Chien Hsin ^c   Chan, Ming Huan ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b TRANSWORLD INSTITUTE OF TECHNOLOGY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 HYDROXYPHENYLGLYCINE; GLUTAMIC ACID; HONOKIOL; MAGNOLOL; METABOTROPIC RECEPTOR 5; N METHYL DEXTRO ASPARTIC ACID; PROSTAGLANDIN E2; PROTEIN C FOS; SUBSTANCE P; 2-CHLORO-5-HYDROXYPHENYLGLYCINE; AMINO ACID RECEPTOR AFFECTING AGENT; ANALGESIC AGENT; ANTIINFECTIVE AGENT; BIPHENYL DERIVATIVE; DRUG DERIVATIVE; GLYCINE; LIGNAN; METABOTROPIC RECEPTOR; N METHYLASPARTIC ACID; PHENYLACETIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BARK; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME INHIBITION; HYPERALGESIA; LICKING; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD DORSAL HORN; ANIMAL; CHEMISTRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; METHODOLOGY;

ANIMALIA; MAGNOLIA OFFICINALIS; MUS;

ANALGESICS; ANIMALS; ANTI-INFECTIVE AGENTS; BIPHENYL COMPOUNDS; DINOPROSTONE; EXCITATORY AMINO ACID AGENTS; GLYCINE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIGNANS; MALE; MICE; N-METHYLASPARTATE; PHENYLACETATES; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 70449447656     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-94     Document Type: Article

References (36)

1. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. P Akerud JM Canals EY Snyder E Arenas, J Neurosci 2001 21 8108 8118 11588183
2. Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat. M Otsuka S Konishi, Nature 1976 264 83 84 10.1038/264083a0 12474
3. Time course of the alteration in dorsal horn substance P levels following formalin: blockade by naloxone. KE McCarson BD Goldstein, Pain 1990 41 95 100 10.1016/0304-3959(90)91113-W 1693764
4. Evidence for vesicular storage of glutamate in primary afferent terminals. J Broman F Adahl, Neuroreport 1994 5 1801 1804 10.1097/00001756- 199409080-00029 7827336
5. Increased spinal release of excitatory amino acids following intradermal injection of capsaicin is reduced by a protein kinase G inhibitor. KA Sluka WD Willis, Brain Res 1998 798 281 286 10.1016/S0006-8993(98)00428-4 9666148
6. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. AB Petrenko T Yamakura H Baba K Shimoji, Anesth Analg 2003 97 1108 1116 10.1213/01.ANE.0000081061.12235.55 14500166
7. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain. IO Medvedev AA Malyshkin IV Belozertseva IA Sukhotina NY Sevostianova K Aliev EE Zvartau CG Parsons W Danysz AY Bespalov, Neuropharmacology 2004 47 175 183 10.1016/j.neuropharm.2004.01.019 15223296
8. [Determination of magnolod and honokiol in different parts of Magnolia officinalis and the effect of processing on their content]. AJ Li, Zhong Yao Tong Bao 1985 10 10 13 2933157
9. [Studies on the components of Magnolia obovata Thunb. 3. Occurrence of magnolol and honokiol in M. obovata and other allied plants]. M Fujita H Itokawa Y Sashida, Yakugaku Zasshi 1973 93 429 434 4738511
10. Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures. YR Lin HH Chen CH Ko MH Chan, Neuropharmacology 2005 49 542 550 10.1016/j.neuropharm.2005.04.009 15921707
11. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. YR Lin HH Chen CH Ko MH Chan, Eur J Pharmacol 2006 537 64 69 10.1016/j.ejphar.2006.03.035 16631734
12. Anti-inflammatory and analgesic effects of magnolol. JP Wang MF Hsu SL Raung CC Chen JS Kuo CM Teng, Naunyn Schmiedebergs Arch Pharmacol 1992 346 707 712 10.1007/BF00168746 1336574
13. Effects of honokiol and magnolol on acute and inflammatory pain models in mice. YR Lin HH Chen CH Ko MH Chan, Life Sci 2007 81 1071 1078 10.1016/j.lfs.2007.08.014 17826802
14. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. A Beirith AR Santos JB Calixto, Brain Res 2002 924 219 228 10.1016/S0006-8993(01)03240-1 11750907
15. Acute effects of nicotine on restraint stress-induced anxiety-like behavior, c-Fos expression, and corticosterone release in mice. HR Hsu TY Chen MH Chan HH Chen, Eur J Pharmacol 2007 566 124 131 10.1016/j.ejphar.2007.03.040 17459372
16. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. J Mao DD Price RL Hayes J Lu DJ Mayer, Brain Res 1992 598 271 278 10.1016/0006-8993(92)90193-D 1362520
17. Receptor localization in the mammalian dorsal horn and primary afferent neurons. RE Coggeshall SM Carlton, Brain Res Brain Res Rev 1997 24 28 66 10.1016/S0165-0173(97)00010-6 9233541
18. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. LM Aanonsen GL Wilcox, J Pharmacol Exp Ther 1987 243 9 19 2822907
19. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. LM Aanonsen S Lei GL Wilcox, Pain 1990 41 309 321 10.1016/0304-3959(90)90008-2 1975091 (Pubitemid 20187934)
20. The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats. AB Malmberg TL Yaksh, Br J Pharmacol 1995 114 1069 1075 7780642
21. Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw. K Omote T Kawamata M Kawamata A Namiki, Brain Res 1998 787 161 164 10.1016/S0006-8993(97)01568-0 9518591
22. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. AH Dickenson AF Sullivan, Neuropharmacology 1987 26 1235 1238 10.1016/0028-3908(87)90275-9 2821443
23. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. SN Davies D Lodge, Brain Res 1987 424 402 406 10.1016/0006-8993(87)91487-9 2823998
24. Metabotropic glutamate receptors - important modulators of nociception and pain behavior. V Neugebauer, Pain 2002 98 1 8 10.1016/S0304-3959(02)00140-9 12098611 (Pubitemid 34722463)
25. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. G Bhave F Karim SM Carlton RWt Gereau, Nat Neurosci 2001 4 417 423 10.1038/86075 11276233
26. Effcts of activation of group III metabotropic glutamate receptors on spinal synaptic transmission in a rat model of neuropathic pain. HM Zhang SR Chen HL Pan, Neuroscience 2009 158 875 884 10.1016/j.neuroscience.2008.10.042 19017536
27. Using c-Fos as a neuronal marker of pain. JA Harris, Brain Research Bulletin 1998 45 1 8 10.1016/S0361-9230(97)00277-3 9434195
28. NMDA receptor antagonists attenuate noxious and nonnoxious colorectal distention-induced Fos expression in the spinal cord and the visceromotor reflex. RJ Traub Q Zhai Y Ji M Kovalenko, Neuroscience 2002 113 205 211 10.1016/S0306-4522(02)00170-7 12123698
29. mGlu5 receptor antagonist decreases Fos expression in spinal neurons after noxious visceral stimulation. R Bianchi R Rezzani E Borsani L Rodella, Brain Res 2003 960 263 266 10.1016/S0006-8993(02)03697-1 12505681
30. In vivo molecular signal transduction of peripheral mechanisms of pain. H Ueda, Jpn J Pharmacol 1999 79 263 268 10.1254/jjp.79.263 10230852
31. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. H Vanegas HG Schaible, Prog Neurobiol 2001 64 327 363 10.1016/S0301-0082(00)00063-0 11275357
32. Intraplantar PGE2 causes nociceptive behaviour and mechanical allodynia: the role of prostanoid E receptors and protein kinases. CA Kassuya J Ferreira RF Claudino JB Calixto, Br J Pharmacol 2007 150 727 737 10.1038/sj.bjp.0707149 17310141
33. The induction of pain: an integrative review. MJ Millan, Prog Neurobiol 1999 57 1 164 10.1016/S0301-0082(98)00048-3 9987804
34. Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice. T Minami J Sugatani K Sakimura M Abe M Mishina S Ito, Br J Pharmacol 1997 120 1522 1526 10.1038/sj.bjp.0701067 9113374
35. Substance P: transmitter of nociception (Minireview). M Zubrzycka A Janecka, Endocr Regul 2000 34 195 201 11137976
36. Molecular mechanisms of nociception. D Julius AI Basbaum, Nature 2001 413 203 210 10.1038/35093019 11557989